FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
This Quarter Return
+13.09%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
AUM
$199M
AUM Growth
+$199M
Cap. Flow
-$26.3M
Cap. Flow %
-13.17%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
1
Reduced
6
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$78.4M 39.37% 3,835,830 -132,070 -3% -$2.7M
AERI
2
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$59.6M 29.91% 1,574,749 -97,965 -6% -$3.71M
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$20.7M 10.39% 995,396 +192,672 +24% +$4.01M
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$18.5M 9.27% 1,526,637 -16,481 -1% -$199K
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
$15.1M 7.6% 679,033 -73,824 -10% -$1.65M
NVET
6
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$3.34M 1.68% 894,695 -5,460 -0.6% -$20.4K
LRMR icon
7
Larimar Therapeutics
LRMR
$310M
$2.11M 1.06% 663,780 -96,266 -13% -$306K
OREX
8
DELISTED
Orexigen Therapeutics, Inc.
OREX
$944K 0.47% 542,755
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
$508K 0.25% +19,910 New +$508K
UAM
10
DELISTED
Universal American Corp
UAM
-2,820,791 Closed -$21.6M
BDSI
11
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-225,281 Closed -$608K